Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2026 09:00 ET | Source: SPR

SPRINT® PNS Publication Highlights Sustained Benefits in Low Back Pain Patients

Long term data published indicated that 79 percent of participants in this SPRINT PNS survey avoided subsequent low back pain interventions.
April 09, 2026 08:00 ET | Source: Curonix LLC

Curonix LLC Announces Appointment of Don Payerle to its Board of Managers, Strengthening Strategic Leadership

“We are pleased to welcome Don Payerle to our Board of Managers,” said Aure Bruneau, Chief Executive Officer of Curonix.
April 02, 2026 10:00 ET | Source: Curonix LLC

Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives Nationwide

Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System
January 16, 2026 08:00 ET | Source: Curonix LLC

Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator (PNS) System as the Only Full-Body PNS Therapy Available in the United States for Craniofacial Pain

Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator System as the Only Full-Body PNS Therapy Available in the US
November 04, 2025 09:00 ET | Source: SPR Therapeutics, Inc.

RESET™ Clinical Trial Demonstrates Superior Pain Relief with SPRINT® PNS Compared to Standard Interventional Management for Chronic Low Back Pain

Clinical trial comparing 60-day PNS to standard interventions demonstrates superior pain relief for low back pain with SPRINT PNS.
October 02, 2025 08:00 ET | Source: Curonix LLC

Curonix Publishes Results for the First and Only IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA 510(k) Expanded Indication for Treating Chronic Craniofacial Pain

Curonix Publishes Results for IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA Expanded Indication for Treating Chronic Craniofacial Pain
September 18, 2025 08:00 ET | Source: Curonix LLC

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution for Chronic Pain of the Head, Neck, Shoulder, and Torso

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution
May 28, 2025 14:00 ET | Source: SPR Therapeutics, Inc.

SPR Announces Publication of Sustained Chronic Shoulder Pain Outcomes Up to Five Years Post-Treatment

SPR announced the peer-reviewed publication of additional survey data demonstrating the impact of SPR® SPRINT® PNS treatment on chronic shoulder pain.
March 27, 2025 08:00 ET | Source: Curonix LLC

Curonix Unveils NervPulse™ Therapy: Setting a New Standard in Nerve-Specific Peripheral Nerve Stimulation (PNS) Therapy

Curonix LLC proudly introduces NervPulseTherapy, an advanced, evidence-based programming platform designed to optimize peripheral nerve stimulation.
December 04, 2024 08:00 ET | Source: Curonix LLC

Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines for the Management of Chronic Pain

Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines